ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

HARP Harpoon Therapeutics Inc

23,01
0,00 (0,00%)
02 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Harpoon Therapeutics Inc HARP NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,00 0,00% 23,01 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
23,01 23,01
mais cotações »

Notícias Recentes

Data Hora Fonte Título
10/01/202417:07PRNUSKuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to..
09/01/202408:12IHMARKETNEWSWall Street Highlights: HPE and Juniper Networks in..
08/01/202409:30BWMerck to Acquire Harpoon Therapeutics, Further Diversifying..
26/12/202309:30GLOBEHarpoon Therapeutics Strengthens Leadership Team
19/12/202309:30GLOBEHarpoon Therapeutics Abstract for HPN328 Accepted for Rapid..
11/12/202322:15GLOBEHarpoon Therapeutics Presents HPN217 Phase 1 Clinical Data..
09/11/202318:01GLOBEHarpoon Therapeutics Reports Third Quarter 2023 Financial..
02/11/202310:15GLOBEHarpoon Therapeutics Abstract for HPN217 Accepted for..
23/10/202308:17GLOBEHarpoon Therapeutics Announces Up to $150 Million Private..
21/10/202312:31GLOBEHarpoon Therapeutics Announces Updated Interim Tolerability..
16/10/202317:05GLOBEHarpoon Therapeutics to Host Webcast Reviewing HPN328..
09/10/202317:17GLOBEHarpoon Therapeutics to Present Interim Tolerability and..
28/09/202304:00GLOBEHarpoon Therapeutics Presents HPN217 Interim Phase 1 Data at..
15/09/202308:15GLOBEHarpoon Therapeutics Announces First Patients with Small..
13/09/202318:12DJNHarpoon Shares Drop 7.3% as AbbVie Declines License Option
13/09/202317:55DJNHarpoon Therapeutics Says AbbVie Declines to Exercise..
13/09/202317:05GLOBEHarpoon Therapeutics Provides an Update on the HPN217..
06/09/202308:30GLOBEHarpoon Therapeutics Abstract for HPN217 Accepted for Poster..
05/09/202309:05GLOBEHarpoon Therapeutics to Host KOL Event in Person and via..
05/09/202309:00GLOBEHarpoon Therapeutics to Participate in Two Upcoming Investor..
09/08/202317:01GLOBEHarpoon Therapeutics Reports Second Quarter 2023 Financial..
03/08/202308:30GLOBEHarpoon Therapeutics to Participate in Two Upcoming Investor..
01/08/202308:30GLOBEHarpoon Therapeutics Appoints Haibo Wang as Senior Vice..
10/07/202310:00PRNUSReplicate Bioscience Appoints Rachael Lester as Chief..
27/06/202308:30GLOBEHarpoon Therapeutics Announces Completion of Planned Patient..
11/05/202317:30GLOBEHarpoon Therapeutics Reports First Quarter 2023 Financial..

Seu Histórico Recente

Delayed Upgrade Clock